India has launched a nationwide single-dose HPV vaccination programme targeting girls aged 14 to combat cervical cancer, which causes over 79,000 deaths annually. This strategic move counters global anti-vaccination sentiments and leverages WHO-recommended single-dose efficacy. Critical focus is on robust AEFI monitoring, recalling a past vaccine trial controversy.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Target Age Group: Girls aged 14
- ›HPV Types Causing Cancer: 16 & 18 (80% of cases)
- ›Target this Data: India's cervical cancer burden in 2022 was 127,526 new cases and 79,906 deaths.
- ›Target this Nodal Body: The programme will be conducted exclusively at designated government health facilities under the Ministry of Health & Family Welfare.
- ›Target this Data: HPV types 16 and 18 together account for over 80% of cervical cancer cases in India.
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.